CHEBI:75043 - Breo Ellipta

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name Breo Ellipta ChEBI ID CHEBI:75043 Definition A mixture composed of vilanterol trifenate and fluticasone furoate (trade name Breo Ellipta) that is used for treatment of bronchospasm associated with chronic obstructive pulmonary disease. Stars This entity has been manually annotated by the ChEBI Team. Wikipedia License Read full article at Wikipedia Roles Classification Biological Role(s): beta-adrenergic agonist An agent that selectively binds to and activates beta-adrenergic receptors. Application(s): beta-adrenergic agonist An agent that selectively binds to and activates beta-adrenergic receptors. bronchodilator agent An agent that causes an increase in the expansion of a bronchus or bronchial tubes. anti-allergic agent A drug used to treat allergic reactions. anti-asthmatic drug A drug used to treat asthma. View more via ChEBI Ontology ChEBI Ontology Outgoing Breo Ellipta (CHEBI:75043) has part fluticasone furoate (CHEBI:74899) Breo Ellipta (CHEBI:75043) has part vilanterol trifenate (CHEBI:75040) Breo Ellipta (CHEBI:75043) has role β-adrenergic agonist (CHEBI:35522) Breo Ellipta (CHEBI:75043) has role anti-allergic agent (CHEBI:50857) Breo Ellipta (CHEBI:75043) has role anti-asthmatic drug (CHEBI:49167) Breo Ellipta (CHEBI:75043) has role bronchodilator agent (CHEBI:35523) Breo Ellipta (CHEBI:75043) is a mixture (CHEBI:60004) Synonyms Sources fluticasone furoate/vilanterol ChEBI fluticasone furoate/vilanterol trifenate ChEBI Manual Xref Database Fluticasone_furoate/vilanterol Wikipedia View more database links Citations Types Sources 22267687 PubMed citation Europe PMC 22738148 PubMed citation Europe PMC 22789766 PubMed citation Europe PMC 23018908 PubMed citation Europe PMC 23200625 PubMed citation Europe PMC 23273165 PubMed citation Europe PMC 23332861 PubMed citation Europe PMC 23352226 PubMed citation Europe PMC 23578031 PubMed citation Europe PMC 23821392 PubMed citation Europe PMC 23846316 PubMed citation Europe PMC Last Modified 31 July 2013